Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors

International Journal of Molecular Sciences

Volumn 15, Issue 12, 2014, Pages 21840-21864

  El Sayed, Ahmed Kamel ^a,b   Zhang, Zhentao ^a   Zhang, Lei ^a   Liu, Zhiyong ^a   Abbott, Louise C ^c   Zhang, Yani ^a   Li, Bichun ^a  

^a YANGZHOU UNIVERSITY   (China)

^b Suez Canal University   (Egypt)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Epigenetics; In vitro transcription; Induced pluripotent stem cells; Pluripotency; Reprogramming

Indexed keywords

MESSENGER RNA; REX PROTEIN; REX1 PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GREEN FLUORESCENT PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DNA INTEGRATION; EMBRYO DEVELOPMENT; EPIGENETICS; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PLASMID; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA TRANSLATION; TERATOMA; UPREGULATION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; EMBRYONIC STEM CELL; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC EPIGENESIS; GENETICS; KINETICS; METABOLISM; PROMOTER REGION; SCID MOUSE;

ANIMALS; BIOMARKERS; CELLULAR REPROGRAMMING; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; INDUCED PLURIPOTENT STEM CELLS; KINETICS; MICE, SCID; OCTAMER TRANSCRIPTION FACTOR-3; PLASMIDS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84912554837     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151221840     Document Type: Article

References (74)

1. Wilmut, I.; Schnieke, A.E.; McWhir, J.; Kind, A.J.; Campbell, K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385, 810–813.
2. Gurdon, J.B.; Wilmut, I. Nuclear transfer to eggs and oocytes. Cold Spring Harb. Perspect. Biol. 2011, 3, doi:10.1101/cshperspect.a002659.
3. Jullien, J.; Pasque, V.; Halley-Stott, R.P.; Miyamoto, K.; Gurdon, J.B. Mechanisms of nuclear reprogramming by eggs and oocytes: A deterministic process? Nat. Rev. Mol. Cell Biol. 2011, 12,453–459.
4. Tada, M.; Takahama, Y.; Abe, K.; Nakatsuji, N.; Tada, T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 2001, 11, 1553–1558.
5. Cowan, C.A.; Atienza, J.; Melton, D.A.; Eggan, K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309, 1369–1373.
6. Yamanaka, S.; Blau, H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010, 465, 704–712.
7. Hansis, C.; Barreto, G.; Maltry, N.; Niehrs, C. Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1. Curr. Biol. 2004, 14, 1475–1480.
8. Freberg, C.T.; Dahl, J.A.; Timoskainen, S.; Collas, P. Epigenetic reprogramming of Oct4 and Nanog regulatory regions by embryonal carcinoma cell extract. Mol. Biol. Cell 2007, 18, 1543–1553.
9. Taranger, C.K.; Noer, A.; Sorensen, A.L.; Hakelien, A.M.; Boquest, A.C.; Collas, P. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell 2005, 16, 5719–5735.
10. Wakayama, T.; Hayashi, Y.; Ogura, A. Participation of the female pronucleus derived from the second polar body in full embryonic development of mice. J. Reprod. Fertil. 1997, 110, 263–266.
11. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663–676.
12. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861–872.
13. Yu, J.; Vodyanik, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; Jonsdottir, G.A.; Ruotti, V.; Stewart, R.; et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917–1920.
14. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322, 949–953.
15. Woltjen, K.; Michael, I.P.; Mohseni, P.; Desai, R.; Mileikovsky, M.; Hamalainen, R.; Cowling, R.; Wang, W.; Liu, P.; Gertsenstein, M. ; et al. Piggybac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458, 766–770.
16. Stadtfeld, M.; Brennand, K.; Hochedlinger, K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr. Biol. 2008, 18, 890–894.
17. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D.A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 2008, 26, 1269–1275.
18. Soldner, F.; Hockemeyer, D.; Beard, C.; Gao, Q.; Bell, G.W.; Cook, E.G.; Hargus, G.; Blak, A.; Cooper, O.; Mitalipova, M. ; et al. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136, 964–977.
19. Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458, 771–775.
20. Miura, K.; Okada, Y.; Aoi, T.; Okada, A.; Takahashi, K.; Okita, K.; Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Ohnuki, M. ; et al. Variation in the safety of induced pluripotent stem cell lines.Nat. Biotechnol. 2009, 27, 743–745.
21. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.; Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R. ; et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1, 55–70.
22. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448, 313–317.
23. Wernig, M.; Meissner, A.; Foreman, R.; Brambrink, T.; Ku, M.; Hochedlinger, K.; Bernstein, B.E.;Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448, 318–324.
24. Brambrink, T.; Foreman, R.; Welstead, G.G.; Lengner, C.J.; Wernig, M.; Suh, H.; Jaenisch, R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008, 2, 151–159.
25. Stadtfeld, M.; Maherali, N.; Breault, D.T.; Hochedlinger, K. Defining molecular cornerstones during fibroblast to ips cell reprogramming in mouse. Cell Stem Cell 2008, 2, 230–240.
26. Sommer, C.A.; Sommer, A.G.; Longmire, T.A.; Christodoulou, C.; Thomas, D.D.; Gostissa, M.; Alt, F.W.; Murphy, G.J.; Kotton, D.N.; Mostoslavsky, G. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 2010, 28, 64–74.
27. Stadtfeld, M.; Nagaya, M.; Utikal, J.; Weir, G.; Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322, 945–949.
28. Zhou, W.; Freed, C.R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 2009, 27, 2667–2674.
29. Fusaki, N.; Ban, H.; Nishiyama, A.; Saeki, K.; Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. 2009, 85, 348–362.
30. Jia, F.; Wilson, K.D.; Sun, N.; Gupta, D.M.; Huang, M.; Li, Z.; Panetta, N.J.; Chen, Z.Y.; Robbins, R.C.; Kay, M.A. ; et al. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 2010, 7, 197–199.
31. Yu, J.; Hu, K.; Smuga-Otto, K.; Tian, S.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324, 797–801.
32. Yusa, K.; Rad, R.; Takeda, J.; Bradley, A. Generation of transgene-free induced pluripotent mouse stem cells by the piggybac transposon. Nat. Methods 2009, 6, 363–369.
33. Kim, D.; Kim, C.H.; Moon, J.I.; Chung, Y.G.; Chang, M.Y.; Han, B.S.; Ko, S.; Yang, E.; Cha, K.Y.; Lanza, R. ; et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4, 472–476.
34. Zhou, H.; Wu, S.; Joo, J.Y.; Zhu, S.; Han, D.W.; Lin, T.; Trauger, S.; Bien, G.; Yao, S.; Zhu, Y. ; et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4,381–384.
35. Lin, S.L.; Chang, D.C.; Chang-Lin, S.; Lin, C.H.; Wu, D.T.; Chen, D.T.; Ying, S.Y. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 2008, 14, 2115–2124.
36. Anokye-Danso, F.; Trivedi, C.M.; Juhr, D.; Gupta, M.; Cui, Z.; Tian, Y.; Zhang, Y.; Yang, W.; Gruber, P.J.; Epstein, J.A. ; et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011, 8, 376–388.
37. Miyoshi, N.; Ishii, H.; Nagano, H.; Haraguchi, N.; Dewi, D.L.; Kano, Y.; Nishikawa, S.; Tanemura, M.; Mimori, K.; Tanaka, F. ; et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011, 8, 633–638.
38. Smits, E.; Ponsaerts, P.; Lenjou, M.; Nijs, G.; van Bockstaele, D.R.; Berneman, Z.N.; van Tendeloo, V.F. RNA-based gene transfer for adult stem cells and T cells. Leukemia 2004, 18, 1898–1902.
39. Wiehe, J.M.; Ponsaerts, P.; Rojewski, M.T.; Homann, J.M.; Greiner, J.; Kronawitter, D.; Schrezenmeier, H.; Hombach, V.; Wiesneth, M.; Zimmermann, O. ; et al. mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression. J. Cell. Mol. Med. 2007, 11, 521–530.
40. Boczkowski, D.; Lee, J.; Pruitt, S.; Nair, S. Dendritic cells engineered to secrete anti-gitr antibodies are effective adjuvants to dendritic cell-based immunotherapy. Cancer Gene Ther. 2009, 16, 900–911.
41. Sul, J.Y.; Wu, C.W.; Zeng, F.; Jochems, J.; Lee, M.T.; Kim, T.K.; Peritz, T.; Buckley, P.; Cappelleri, D.J.; Maronski, M. ; et al. Transcriptome transfer produces a predictable cellular phenotype. Proc. Natl. Acad. Sci. USA 2009, 106, 7624–7629.
42. Melhem, N.M.; Liu, X.D.; Boczkowski, D.; Gilboa, E.; Barratt-Boyes, S.M. Robust CD4+ and CD8+ T cell responses to siv using mRNA-transfected DC expressing autologous viral Ag. Eur. J. Immunol. 2007, 37, 2164–2173.
43. Lee, J.; Dollins, C.M.; Boczkowski, D.; Sullenger, B.A.; Nair, S. Activated b cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses. Immunology 2008, 125, 229–240.
44. Kim, T.K.; Sul, J.Y.; Peternko, N.B.; Lee, J.H.; Lee, M.; Patel, V.V.; Kim, J.; Eberwine, J.H. Transcriptome transfer provides a model for understanding the phenotype of cardiomyocytes. Proc. Natl. Acad. Sci. USA 2011, 108, 11918–11923.
45. Plews, J.R.; Li, J.; Jones, M.; Moore, H.D.; Mason, C.; Andrews, P.W.; Na, J. Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach. PLoS One 2010, 5, e14397.
46. Yakubov, E.; Rechavi, G.; Rozenblatt, S.; Givol, D. Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem. Biophys. Res. Commun. 2010, 394, 189–193.
47. Arnold, A.; Naaldijk, Y.M.; Fabian, C.; Wirth, H.; Binder, H.; Nikkhah, G.; Armstrong, L.; Stolzing, A. Reprogramming of human huntington fibroblasts using mRNA. ISRN Cell Biol. 2012, 2012, 12.
48. Warren, L.; Manos, P.D.; Ahfeldt, T.; Loh, Y.H.; Li, H.; Lau, F.; Ebina, W.; Mandal, P.K.; Smith, Z.D.; Meissner, A. ; et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7, 618–630.
49. Mandal, P.K.; Rossi, D.J. Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat. Protoc. 2013, 8, 568–582.
50. Durruthy-Durruthy, J.; Briggs, S.F.; Awe, J.; Ramathal, C.Y.; Karumbayaram, S.; Lee, P.C.; Heidmann, J.D.; Clark, A.; Karakikes, I.; Loh, K.M. ; et al. Rapid and efficient conversion of integration-free human induced pluripotent stem cells to gmp-grade culture conditions. PLoS One 2014, 9, e94231.
51. Tavernier, G.; Wolfrum, K.; Demeester, J.; De Smedt, S.C.; Adjaye, J.; Rejman, J. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc. Biomaterials 2012, 33, 412–417.
52. Sullenger, B.A.; Gilboa, E. Emerging clinical applications of RNA. Nature 2002, 418, 252–258.
53. Ponsaerts, P.; van Tendeloo, V.F.; Berneman, Z.N. Cancer immunotherapy using RNA-loaded dendritic cells. Clin. Exp. Immunol. 2003, 134, 378–384.
54. Saeboe-Larssen, S.; Fossberg, E.; Gaudernack, G. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J. Immunol. Methods 2002, 259, 191–203.
55. Ponsaerts, P.; van Tendeloo, V.F.; Cools, N.; van Driessche, A.; Lardon, F.; Nijs, G.; Lenjou, M.; Mertens, G.; van Broeckhoven, C.; van Bockstaele, D.R. ; et al. mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia 2002, 16, 1324–1330.
56. Muller, M.R.; Tsakou, G.; Grunebach, F.; Schmidt, S.M.; Brossart, P. Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells. Blood 2004, 103, 1763–1769.
57. Van Tendeloo, V.F.; van Broeckhoven, C.; Berneman, Z.N. Gene therapy: Principles and applications to hematopoietic cells. Leukemia 2001, 15, 523–544.
58. Yisraeli, J.K.; Melton, D.A. Synthesis of long, capped transcripts in vitro by SP6 and T7 RNA polymerases. Methods Enzymol. 1989, 180, 42–50.
59. Diebold, S.S.; Kaisho, T.; Hemmi, H.; Akira, S.; Reis e Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303, 1529–1531.
60. Hornung, V.; Ellegast, J.; Kim, S.; Brzozka, K.; Jung, A.; Kato, H.; Poeck, H.; Akira, S.; Conzelmann, K.K.; Schlee, M.; et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314, 994–997.
61. Pichlmair, A.; Schulz, O.; Tan, C.P.; Naslund, T.I.; Liljestrom, P.; Weber, F.; Reis e Sousa, C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314, 997–1001.
62. Kawai, T.; Akira, S. Antiviral signaling through pattern recognition receptors. J. Biochem. 2007, 141, 137–145.
63. Uematsu, S.; Akira, S. Toll-like receptors and type I interferons. J. Biol. Chem. 2007, 282, 15319–15323.
64. Angel, M.; Yanik, M.F. Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 2010, 5, e11756.
65. Drews, K.; Tavernier, G.; Demeester, J.; Lehrach, H.; de Smedt, S.C.; Rejman, J.; Adjaye, J. The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts. Biomaterials 2012, 33, 4059–4068.
66. Van Tendeloo, V.F.; Willems, R.; Ponsaerts, P.; Lenjou, M.; Nijs, G.; Vanhove, M.; Muylaert, P.; van Cauwelaert, P.; van Broeckhoven, C.; van Bockstaele, D.R.; et al. High-level transgene expression in primary human t lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery. Gene Ther. 2000, 7, 1431–1437.
67. Jin, J.; Kwon, Y.W.; Paek, J.S.; Cho, H.J.; Yu, J.; Lee, J.Y.; Chu, I.S.; Park, I.H.; Park, Y.B.; Kim, H.S. ; et al. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts. J. Proteome Res. 2011, 10, 977–989.
68. Chan, E.M.; Ratanasirintrawoot, S.; Park, I.H.; Manos, P.D.; Loh, Y.H.; Huo, H.; Miller, J.D.; Hartung, O.; Rho, J.; Ince, T.A. ; et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 2009, 27, 1033–1037.
69. Smith, Z.D.; Nachman, I.; Regev, A.; Meissner, A. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat. Biotechnol. 2010, 28, 521–526.
70. Simonsson, S.; Gurdon, J. DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat. Cell Biol. 2004, 6, 984–990.
71. Robinton, D.A.; Daley, G.Q. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481, 295–305.
72. Stadtfeld, M.; Hochedlinger, K. Induced pluripotency: History, mechanisms, and applications. Genes Dev. 2010, 24, 2239–2263.
73. Mitsui, K.; Tokuzawa, Y.; Itoh, H.; Segawa, K.; Murakami, M.; Takahashi, K.; Maruyama, M.; Maeda, M.; Yamanaka, S. The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113, 631–642.
74. Nagy, A.; Gertsenstein, M.; Vintersten, K.; Behringer, R. Karyotyping mouse cells. CSH Protoc. 2008, 2008, doi:10.1101/pdb.prot4706.